Monoclonal therapeutics and diagnostic antibodies market worth $56 billion by 2012
The monoclonal therapeutic and diagnostic antibodies market is expected to increase by 80% by 2012, according to a technical market research report by BCC Research.
Titled Monoclonal Therapeutics and Diagnostic Imaging Products: The Global Market (Bio016g), the report showed the global market for monoclonal therapeutic and diagnostic antibodies was worth $31 billion in 2007. This is expected to increase to over $56 billion by 2012, a compound average annual growth rate (CAGR) of 13%.
For more information on the report, visit www.bccresearch.com.
Tiny antibody found to neutralise Hendra and Nipah viruses
There are no approved human vaccines for either disease, nor are there any known cures —...
Llama antibodies open door to future coronavirus protection
Researchers have discovered a novel class of small antibodies that are strongly protective...
AI predicts bacteria's resistance to cleaning agents
With DNA data and machine learning, accurate bacterial resistance predictions can be made in...
